Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of MiMedx (Nasdaq: MDXG) concerning possible breaches of fiduciary duty arising from, among other things, allegations by the U.S. Food and Drug Administration that MiMedx committed regulatory violations involving certain of its products.
Shareholders interested in seeking to recover damages on behalf of MDXG and to implement corporate governance measures designed to prevent future misconduct should contact the firm.
If you hold MDXG shares and you would like to discuss your legal rights, please email the firm at info@hkh-lawfirm.com. You can also contact us by calling Michael J. Hynes at (610) 994-0292 or by sending an e-mail to mhynes@hkh-lawfirm.com.